Journal of Pharmacology and Pharmacotherapeutics

CASE REPORT
Year
: 2014  |  Volume : 5  |  Issue : 2  |  Page : 161--162

Tumor lysis syndrome in multiple myeloma treated with bortezomib


KM Dhanraj, Dubashi Biswajit 
 Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India

Correspondence Address:
K M Dhanraj
Department of Medical oncology, Regional Cancer Centre, JIPMER, Pondicherry - 605 006
India

A 65 year old male diagnosed as multiple myeloma was started on bortezomib developed tumor lysis syndrome. Bortezomib induced tumor lysis is rare and suitable precautions should be considered in these patients.


How to cite this article:
Dhanraj K M, Biswajit D. Tumor lysis syndrome in multiple myeloma treated with bortezomib.J Pharmacol Pharmacother 2014;5:161-162


How to cite this URL:
Dhanraj K M, Biswajit D. Tumor lysis syndrome in multiple myeloma treated with bortezomib. J Pharmacol Pharmacother [serial online] 2014 [cited 2020 May 30 ];5:161-162
Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2014;volume=5;issue=2;spage=161;epage=162;aulast=Dhanraj;type=0